Based on the provided information, there is no specific data or studies that directly address how Cosentyx (secukinumab) affects live vaccine administration. However, the National Center for Biotechnology Information (NCBI) article [1] does mention that biologic therapies, such as Cosentyx, can have an impact on the immune system's response to vaccines.

The Cosentyx website [3] states that patients should follow general vaccine recommendations, but it does not provide specific guidance for live vaccine administration. It is recommended to consult with a healthcare provider for personalized advice.

It is important to note that the FDA has not approved any COVID-19 vaccines for use in combination with biologic therapies like Cosentyx [2]. Therefore, it is crucial to consult with a healthcare provider for specific guidance regarding vaccine administration while on Cosentyx therapy.

In summary, there is no direct information available on how Cosentyx affects live vaccine administration. However, biologic therapies like Cosentyx can impact the immune system's response to vaccines, and it is important to consult with a healthcare provider for personalized advice.

Sources:
[1] <https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767096/>
[2] <https://www.cosentyx.com/all/covid19>
[3] <https://www.drugpatentwatch.com/p/biologics/tradename/COSENTYX>